The treatment of Cancer Risk Reduction & Prostadynia with vitamins

Cancer Risk Reduction and Prostadynia: Mitamins custom make quality formulas for the treatment of Cancer Risk Reduction & Prostadynia with vitamins. A Cancer Risk Reduction & Prostadynia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cancer Risk Reduction and Prostadynia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Zinc
    10
    mg
    67%
    Selenium
    100
    mcg
    143%
    Copper
    1
    mg
    50%
    CoQ-10
    15
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Quercetin
    500
    mg
    *
    Saw Palmetto Extract
    80
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    Bromelain
    500
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cancer Risk Reduction and Prostadynia
Monthly Cost: $43.76
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Cancer Risk Reduction and Prostadynia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Varian Medical Systems Receives FDA 510(k) Clearance For High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
Varian Medical Systems, Inc. (NYSE: VAR) has received FDA 510(k) clearance for a new high-definition multileaf collimator (MLC), an ultra-fine beam shaping device for radiosurgery.
Steroids Seem Safe for Babies at Risk of Early Birth (HealthDay)
Children exposed to repeated doses of steroids in-utero had no additional growth or neurodevelopmental problems up to three years after birth, two new studies found.
This information concerning the support of Cancer Risk Reduction and Prostadynia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Cancer & Chemo  Cancer Risk Reduction  Cancer Risk Reduction and Prostadynia
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments